Perpetual Ltd’s ResMed RMD Stock Holding History

Perpetual Ltd’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,754	Closed	-$630K	–	431
2024 Q4	$630K	Buy	+2,754	New	+$663K	0.01%	300
2014 Q1	–	Sell	-36,730	Closed	-$1.73M	–	223
2013 Q4	$1.73M	Sell	36,730 -410	-1%	-$20.8K	0.23%	92
2013 Q3	$1.96M	Sell	37,140 -2,040	-5%	-$99K	0.28%	76
2013 Q2	$1.77M	Buy	+39,180	New	+$1.86M	0.27%	82

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Perpetual Ltd's RMD Position: Q1 2025 in Review

Perpetual Ltd sold out of ResMed (RMD) in Q1 2025, closing a stake of 2,754 shares — an estimated $630K sold.

Perpetual Ltd first reported a position in RMD in Q2 2013 and held it in 4 quarters. The position peaked at $1.96M in Q3 2013. 885 funds tracked by Wall St. Rank hold RMD as of Q1 2025.

Perpetual Ltd reported no remaining ResMed position as of Q1 2025 after selling out during the quarter.
Perpetual Ltd sold 2,754 ResMed shares in Q1 2025, an estimated $630K.
Perpetual Ltd first reported a position in ResMed in Q2 2013 and held it in 4 quarters.
Perpetual Ltd's ResMed position peaked at $1.96M in Q3 2013.
885 funds tracked by Wall St. Rank held ResMed as of Q1 2025.

Based on Perpetual Ltd's 13F filing for Q1 2025, filed 24 Apr 2025.